» Authors » Jorge L Gamboa

Jorge L Gamboa

Explore the profile of Jorge L Gamboa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 855
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dilaver R, Demirci M, Crescenzi R, Pridmore M, Ertuglu L, Guide A, et al.
medRxiv . 2025 Feb; PMID: 39974089
Background And Aims: Sarcopenia, defined as a loss in muscle mass and strength, is common in patients with advanced chronic kidney disease (CKD), leading to poor outcomes. Intermuscular adipose tissue...
2.
Ahmadi A, Valencia A, Begue G, Norman J, Fan S, Durbin-Johnson B, et al.
Clin J Am Soc Nephrol . 2025 Jan; 20(3):346-357. PMID: 39847432
No abstract available.
3.
Hayden C, Begue G, Gamboa J, Baar K, Roshanravan B
Kidney Int Rep . 2024 Nov; 9(11):3097-3115. PMID: 39534200
Exercise interventions in chronic kidney disease (CKD) have received growing interest, with over 30 meta-analyses published in the past 5 years. The potential benefits of exercise training in CKD range...
4.
Ahmadi A, Valencia A, Begue G, Norman J, Fan S, Durbin-Johnson B, et al.
medRxiv . 2024 Sep; PMID: 39228730
Background: Mitochondria-driven oxidative/redox stress and inflammation play a major role in chronic kidney disease (CKD) pathophysiology. Compounds targeting mitochondrial metabolism may improve mitochondrial function, inflammation, and redox stress; however, there...
5.
Ertuglu L, Sahinoz M, Alsouqi A, Deger S, Guide A, Pike M, et al.
Physiol Rep . 2024 Jul; 12(13):e16127. PMID: 38960895
Background And Aims: High tissue sodium accumulation and intermuscular adipose tissue (IMAT) are associated with aging, type 2 diabetes, and chronic kidney disease. In this study, we aim to investigate...
6.
Mashayekhi M, Nian H, Mayfield D, Devin J, Gamboa J, Yu C, et al.
Diabetes . 2023 Oct; 73(1):38-50. PMID: 37874653
Article Highlights: Metabolic benefits of glucagon-like peptide 1 (GLP-1) receptor agonists are confounded by weight loss and are not fully achieved by increasing endogenous GLP-1 through dipeptidyl peptidase 4 (DPP-4)...
7.
Gamboa J, Mambungu C, Clagett A, Nian H, Yu C, Ikizler T, et al.
BMC Nephrol . 2023 May; 24(1):134. PMID: 37170244
Introduction: Intradialytic hypotension (IDH) is a common clinical complication and is associated with increased morbidity and mortality in patients undergoing maintenance hemodialysis (MHD). The pathogenesis of IDH has been attributed...
8.
Chung C, Karakoc G, Dickson A, Liu G, Gamboa J, Mosley J, et al.
Lupus . 2023 Apr; 32(6):763-770. PMID: 37105192
Background: Systemic lupus erythematosus (SLE) disproportionately affects individuals of African ancestry (AA) compared to European ancestry (EA). In the general population, high risk (HR) variants in the apolipoprotein L1 (...
9.
Chung C, Karakoc G, Liu G, Gamboa J, Mosley J, Cox N, et al.
Lupus Sci Med . 2022 Nov; 9(1). PMID: 36376015
Objective: SLE is more prevalent in populations of African (AA) than European ancestry (EA) and leucopenia is common. A homozygous variant in (rs2814778-CC) is associated with lower white cell counts;...
10.
Shi M, Wang C, Mei H, Temprosa M, Florez J, Tripputi M, et al.
J Am Heart Assoc . 2022 May; 11(11):e024388. PMID: 35621206
Background Elevated plasma levels of alpha-aminoadipic acid (2-AAA) have been associated with the development of type 2 diabetes and atherosclerosis. However, the nature of the association remains unknown. Methods and...